Longitudinal Clinical Performance of the RNA-Based Aptima Human Papillomavirus (AHPV) Assay in Comparison to the DNA-Based Hybrid Capture 2 HPV Test in Two Consecutive Screening Rounds with a 6-Year Interval in Germany

Autor: Alejandra Castanon, Sara Y. Brucker, Rebecca Landy, Claus Hann von Weyhern, Juliane Haedicke-Jarboui, Barbara Holz, Melanie Henes, Felix Neis, Thomas Iftner, Annette Staebler, Klaus-Joachim Neis, Peter Martus, Angelika Iftner, Diethelm Wallwiener, Astrid Woll-Herrmann, Peter Sasieni

Publikováno v: Iftner, T, Neis, K-J, Castanon, A, Landy, R, Holz, B, Woll-Herrmann, A, Iftner, A, Staebler, A, Wallwiener, D, von Weyhern, C H, Neis, F, Haedicke-Jarboui, J, Martus, P, Brucker, S, Henes, M & Sasieni, P 2019, ' Longitudinal Clinical Performance of the RNA-Based Aptima Human Papillomavirus (AHPV) Assay in Comparison to the DNA-Based Hybrid Capture 2 HPV Test in Two Consecutive Screening Rounds with a 6-Year Interval in Germany ', Journal of Clinical Microbiology, vol. 57, no. 1, e01177 . https://doi.org/10.1128/JCM.01177-18
Journal of Clinical Microbiology

Longitudinal data on the E6/E7 mRNA-based Aptima human papillomavirus (AHPV) assay exceeding three years in comparison to the gold standard Digene Hybrid Capture 2 (HC2) test are not available. We previously reported the cross-sectional data of the G

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32e4389dd71c2a3aa5feb02b0c479ca5
https://kclpure.kcl.ac.uk/ws/files/108890998/Journal_of_Clinical_Microbiology_2018_Iftner_JCM.01177_18.full.pdf